Mestag Therapeutics announced that it has entered into a license and collaboration agreement with MSD to identify novel targets for the development of therapies against inflammatory diseases.
Synexa Life Sciences, a specialist biomarker and bioanalysis service provider, announced the acquisition of Alderley Analytical Ltd, based near Manchester, UK.
Gerresheimer together with Stevanato Group, and SCHOTT Pharma, have announced that they have entered into a strategic industry alliance ("Alliance for RTU").
Lonza announced it has completed its acquisition of the Genentech large-scale biologics manufacturing site in Vacaville, California (US) from Roche for USD 1.2 billion.
PCI Pharma Services, (“PCI”) a global contract development and manufacturing organisation (CDMO) focused on biopharma’s most complex therapies, is investing more than $365 million in infrastructure.
Molex, parent company of Phillips Medisize, has announced that it has signed an agreement to purchase Vectura Group Limited, a leader in inhalation drug device design and formulation.
DevCo Partners Ltd has announced a capital raise resulting in 616 MEUR of total commitments for its long-term single asset investment vehicle for Medix Biochemica.
